Covalon Technologies Ltd. (COV.V)
| Previous Close | 3.2500 |
| Open | 3.2500 |
| Bid | 3.2000 x 0 |
| Ask | 3.2200 x 0 |
| Day's Range | 3.2400 - 3.2500 |
| 52 Week Range | 0.9600 - 3.3100 |
| Volume | |
| Avg. Volume | 27,693 |
| Market Cap | 80.183M |
| Beta (5Y Monthly) | 0.64 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
Covalon Technologies Ltd. to Showcase Innovative Vascular Access Solutions at the Annual Association of Pediatric Hematology/Oncology Nurses Conference
MISSISSAUGA, Ontario, September 11, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its participation in the Association of Pediatric Hematology/Oncology Nurses (APHON) Annual 2024 Conference. The conference, taking place in Salt Lake City, Utah from September 11 to 13, is a premier event for pediatric hematology/oncology nursing professionals involved in patient care, education, case management, an
- Business Wire
Covalon Announces Strong Third Quarter Fiscal 2024 Results
MISSISSAUGA, Ontario, August 21, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2024 third quarter results for the period ended June 30, 2024.
- Business Wire
Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2024 Financial Results
MISSISSAUGA, Ontario, August 14, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q3 Fiscal 2024 financial results on Wednesday, August 21, 2024, before markets open. A conference call and webcast to discuss the financial results will be held on Wednesday, August 21, 2024, at 8:30am ET.
